FORM OF PLACEMENT AGENCY AGREEMENTAgency Agreement • January 8th, 2013 • MusclePharm Corp • Pharmaceutical preparations • Colorado
Contract Type FiledJanuary 8th, 2013 Company Industry JurisdictionMusclePharm Corporation, a Nevada corporation (the “Company”), proposes, subject to the terms and conditions herein, to issue and sell an aggregate of up to [•] shares (the “Shares”) of its Series D Convertible preferred stock, $0.001 par value per share (the “Series D Preferred”), which are convertible into shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), to certain investors in a registered offering. The terms of the Series D Preferred will be set forth in a certificate of designation (the “Certificate of Designation”) to be filed by the Company with the Secretary of State of the State of Nevada. The Company desires to engage GVC Capital LLC (the “Placement Agent”) as an exclusive placement agent in connection with such issuance and sale of the Shares.
FORM OF PLACEMENT AGENCY AGREEMENTAgency Agreement • December 31st, 2012 • MusclePharm Corp • Pharmaceutical preparations • New York
Contract Type FiledDecember 31st, 2012 Company Industry Jurisdiction
FORM OF PLACEMENT AGENCY AGREEMENTAgency Agreement • December 26th, 2012 • MusclePharm Corp • Pharmaceutical preparations • New York
Contract Type FiledDecember 26th, 2012 Company Industry Jurisdiction